Reducing Out-of-Pocket Cost Barriers to Specialty Drug Use Under Medicare Part D

Research presented by Jalpa A. Doshi, PhD, associate professor of medicine, director, Economic Evaluations Unit, Center for Evidence-based Practice, and director, Value-based Insurance Design Initiatives, Center for Health Incentives and Behavioral Economics, University of Pennsylvania, the Cost-Sharing Roundtable: Sustainable Strategies for Providing Access to Critical Medications. The event was co-hosted by the PAN Foundation and The American Journal of Managed Care®.

Related Videos

Related Content

Advertisement

July 22nd 2025

States Target Medicaid QIPs to Improve Health Access, Outcomes

Pearl Steinzor

Mental health, care of acute and chronic conditions, primary care access and prevention, and maternal and perinatal health were identified as key focus areas among a majority of states.

May 29th 2025

Laundromats as a New Frontier in Community Health, Medicaid Outreach

Brooke McCormick Lindsey Jeanne Leininger, PhD Allister Chang, MPA

Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.

July 21st 2025

Primary Care Doctors Lead Rising Physician Exodus From Medicare

Maggie L. Shaw

According to the American Medical Association, blame for the ongoing physician shortage may lie with overly burdensome administrative processes, an antiquated Medicare payment system, and lack of education for residents in primary care and psychiatry.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

July 17th 2025

Direct-to-Patient Apixaban Program Aims to Expand Access, Lower Out-of-Pocket Costs

Hayden E. Klein

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

July 15th 2025

Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD

Hayden E. Klein Robert Kratzke, MD

Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving.

Related Content

Advertisement

July 22nd 2025

States Target Medicaid QIPs to Improve Health Access, Outcomes

Pearl Steinzor

Mental health, care of acute and chronic conditions, primary care access and prevention, and maternal and perinatal health were identified as key focus areas among a majority of states.

May 29th 2025

Laundromats as a New Frontier in Community Health, Medicaid Outreach

Brooke McCormick Lindsey Jeanne Leininger, PhD Allister Chang, MPA

Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.

July 21st 2025

Primary Care Doctors Lead Rising Physician Exodus From Medicare

Maggie L. Shaw

According to the American Medical Association, blame for the ongoing physician shortage may lie with overly burdensome administrative processes, an antiquated Medicare payment system, and lack of education for residents in primary care and psychiatry.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

July 17th 2025

Direct-to-Patient Apixaban Program Aims to Expand Access, Lower Out-of-Pocket Costs

Hayden E. Klein

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

July 15th 2025

Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD

Hayden E. Klein Robert Kratzke, MD

Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving.